Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Reference

PAR-25-096

Agency

National Institutes of Health

Posted

2024-11-18

Deadline

2026-11-17

Source status

posted at retrieval

Country

United States (funding region); applicant eligibility varies

Listing numbers

93.393, 93.121, 93.172, 93.866

Retrieved

2026-11-10T18:56:52.593Z

Read the official call before applying

Check the full description, funding amounts, eligibility, required documents and any amendments with the official funder. Additional restrictions and application instructions may not be included in this directory.